Related Experiment Video
Updated: Jun 28, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis
Vugar Yagublu1, Bayram Bayramov2,3, Christoph Reissfelder4,5
1Department of Surgery, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. vugar.yagublu@umm.de.
Abstract:
Chemotherapy drugs efficiently eradicate rapidly dividing differentiated cells by inducing cell death, but poorly target slowly dividing cells, including cancer stem cells and dormant cancer cells, in the later course of treatment. Prolonged exposure to chemotherapy results in a decrease in the proportion of apoptotic cells in the tumour mass. To investigate and characterize the molecular basis of this phenomenon, microarray-based expression analysis was performed to compare tHcred2-DEVD-EGFP-caspase 3-sensor transfected C-26 tumour cells that were harvested after engraftment into mice treated with or without 5-FU. Peritoneal metastasis was induced by intraperitoneal injection of C-26 cells, which were subsequently reisolated from omental metastatic tumours after the mice were sacrificed by the end of the 10th day after tumour injection. The purity of reisolated tHcred2-DEVD-EGFP-caspase 3-sensor-expressing C-26 cells was confirmed using FLIM, and total RNA was extracted for gene expression profiling. The validation of relative transcript levels was carried out via real-time semiquantitative RT‒PCR assays. Our results demonstrated that chemotherapy induced the differential expression of mediators of cancer cell dormancy and cell survival-related genes and downregulation of both intrinsic and extrinsic apoptotic signalling pathways. Despite the fact that some differentially expressed genes, such as BMP7 and Prss11, have not been thoroughly studied in the context of chemoresistance thus far, they might be potential candidates for future studies on overcoming drug resistance.
Insights
Chemotherapy fails to eliminate dormant cancer cells, leading to decreased apoptosis. This study reveals chemotherapy alters gene expression, promoting cell survival and dormancy, suggesting new targets for overcoming drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Chemotherapy effectively targets rapidly dividing cells but struggles with slow-dividing cancer stem cells and dormant cells.
- Prolonged chemotherapy exposure paradoxically reduces the proportion of apoptotic cells within tumors.
Purpose of the Study:
- To investigate the molecular mechanisms behind chemotherapy-induced decrease in apoptosis in tumors.
- To identify genes and pathways involved in cancer cell dormancy and survival during chemotherapy.
Main Methods:
- Microarray-based gene expression analysis of 5-fluorouracil (5-FU) treated and untreated C-26 tumor cells.
- Utilized a caspase-3 sensor (tHcred2-DEVD-EGFP) for monitoring apoptosis.
- Confirmed cell purity with Fluorescence Lifetime Imaging (FLIM) and validated gene expression via RT-qPCR.
Main Results:
- Chemotherapy induced differential expression of genes related to cancer cell dormancy and survival.
- Observed downregulation of both intrinsic and extrinsic apoptotic signaling pathways.
- Identified BMP7 and Prss11 as potentially significant differentially expressed genes.
Conclusions:
- Chemotherapy promotes cancer cell dormancy and survival by altering gene expression and suppressing apoptosis.
- BMP7 and Prss11 represent potential therapeutic targets for overcoming chemoresistance.

